150 related articles for article (PubMed ID: 30863167)
21. Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma.
Della Corte A; Ratti F; Monfardini L; Marra P; Gusmini S; Salvioni M; Venturini M; Cipriani F; Aldrighetti L; De Cobelli F
Int J Hyperthermia; 2020; 37(1):542-548. PubMed ID: 32469252
[No Abstract] [Full Text] [Related]
22. Percutaneous ablative therapies for hepatocellular carcinoma in the caudate lobe of the liver: efficacy and outcome.
Mukund A; Tripathy TP; Patel RK; Chandel K; Patidar Y; Jindal A; Sarin SK
Br J Radiol; 2023 Aug; 96(1148):20220086. PubMed ID: 37227887
[TBL] [Abstract][Full Text] [Related]
23. Assessment of safety margin after microwave ablation of stage I NSCLC with three-dimensional reconstruction technique using CT imaging.
Yan P; Tong AN; Nie XL; Ma MG
BMC Med Imaging; 2021 Jun; 21(1):96. PubMed ID: 34098894
[TBL] [Abstract][Full Text] [Related]
24. MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
Li Z; Wang C; Li J; Liu Z; Jiao D; Han X
BMC Cancer; 2021 May; 21(1):562. PubMed ID: 34001036
[TBL] [Abstract][Full Text] [Related]
25. Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllability.
Minami Y; Minami T; Takita M; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
Hepatol Res; 2020 Jan; 50(1):67-74. PubMed ID: 31301213
[TBL] [Abstract][Full Text] [Related]
26. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
[TBL] [Abstract][Full Text] [Related]
27. A measure to assess the ablative margin using 3D-CT image fusion after radiofrequency ablation of hepatocellular carcinoma.
Tang H; Tang Y; Hong J; Chen T; Mai C; Jiang P
HPB (Oxford); 2015 Apr; 17(4):318-25. PubMed ID: 25346478
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound fusion imaging technologies for guidance in ablation therapy for liver cancer.
Minami Y; Kudo M
J Med Ultrason (2001); 2020 Apr; 47(2):257-263. PubMed ID: 32125577
[TBL] [Abstract][Full Text] [Related]
29. Application and Evaluation of a 64-Slice CT Three-Dimensional Fusion Technique in the Determination of the Effective Ablation Margin after Radiofrequency Ablation of Hepatocellular Carcinoma.
Du H; Tan X; Cheng L; Zhang B; Wang D
Comput Math Methods Med; 2022; 2022():6898233. PubMed ID: 35126633
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ultrasonography-guided percutaneous microwave ablation for subcapsular and nonsubcapsular hepatocellular carcinoma.
Liu F; Yu X; Cheng Z; Han Z; Sun Y; Liang P; Zhou F
Eur J Radiol; 2017 Jun; 91():93-98. PubMed ID: 28629577
[TBL] [Abstract][Full Text] [Related]
31. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound-guided percutaneous microwave ablation assisted by a three-dimensional visualization preoperative treatment planning system for larger adrenal metastasis (D ≥ 4 cm): Preliminary results.
Wu S; Li X; Yu J; Yu X; Cheng Z; Liu F; Han Z; Duan S; Liang P
J Cancer Res Ther; 2019; 15(7):1477-1483. PubMed ID: 31939425
[TBL] [Abstract][Full Text] [Related]
33. The value of 3D visualization operative planning system in ultrasound-guided percutaneous microwave ablation for large hepatic hemangiomas: a clinical comparative study.
Li X; An C; Liu F; Cheng Z; Han Z; Yu X; Dong L; Yu J; Liang P
BMC Cancer; 2019 Jun; 19(1):550. PubMed ID: 31174503
[TBL] [Abstract][Full Text] [Related]
34. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma.
Medhat E; Abdel Aziz A; Nabeel M; Elbaz T; Zakaria Z; Shousha H; Amer A; Fouad Fathalah W; Maher R; Musa S
J Dig Dis; 2015 Aug; 16(8):456-63. PubMed ID: 25958973
[TBL] [Abstract][Full Text] [Related]
35. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
[TBL] [Abstract][Full Text] [Related]
36. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging.
Jiang C; Liu B; Chen S; Peng Z; Xie X; Kuang M
Int J Hyperthermia; 2018 Dec; 34(8):1135-1141. PubMed ID: 29392978
[TBL] [Abstract][Full Text] [Related]
37. Ultrasound-guided percutaneous microwave ablation vs. surgical resection for thoracoabdominal wall implants from hepatocellular carcinoma: intermediate-term results.
An C; Hu ZL; Liang P; Cheng ZG; Han ZY; Yu J; Liu FY
Int J Hyperthermia; 2018 Nov; 34(7):1067-1076. PubMed ID: 29161924
[TBL] [Abstract][Full Text] [Related]
38. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
39. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular Carcinoma.
Zhang X; Huang G; Ye J; Xu M; Cong L; He X; Huang T; Kuang M; Xie X
Ultrasound Med Biol; 2019 Aug; 45(8):1933-1943. PubMed ID: 31109841
[TBL] [Abstract][Full Text] [Related]
40. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases.
Dou JP; Yu J; Han ZY; Liu FY; Cheng ZG; Liang P
Abdom Radiol (NY); 2017 Mar; 42(3):962-968. PubMed ID: 27688061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
